Population Pharmacokinetic Analysis of Itacitinib, a Selective JAK-1 Inhibitor

被引：0
|
作者：
Barbour, April Marie [1 ]
Chen, Xuejun [1 ]
Yeleswaram, Swamy [1 ]
机构：
[1] Incyte Res Inst, Drug Metab & Biopharmaceut, Wilmington, DE USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
360
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Dosing Strategy for Itacitinib, a Selective JAK1 Inhibitor, for the Treatment of Ulcerative Colitis
    Barbour, April
    Zhang, Yan
    Punwani, Naresh
    Diamond, Sharon
    Chen, Xuejun
    Yeleswaram, Swamy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S136 - S136
  • [2] Efficacy and safety of upadacitinib, a selective JAK-1 inhibitor in treatment of ankylosing spondylitis: a meta-analysis
    Yao, Qi
    Zhu, Yixuan
    Ma, Yanling
    Pu, Yanfang
    Yang, Xueting
    Zhang, Zhiqing
    BMC RHEUMATOLOGY, 2025, 9 (01)
  • [3] Novel Management of Masticatory Myositis in Three Dogs with a Selective Janus Kinase (JAK-1) Inhibitor
    Congiusta, Michael C.
    Snyder, Christopher
    Soukup, Jason W.
    Apostolopoulos, Neoklis
    JOURNAL OF VETERINARY DENTISTRY, 2024, 41 (06) : 620 - 627
  • [4] A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
    Schroeder, Mark A.
    Khoury, H. Jean
    Jagasia, Madan
    Ali, Haris
    Schiller, Gary J.
    Staser, Karl
    Choi, Jaebok
    Gehrs, Leah
    Arbushites, Michael C.
    Yan, Ying
    Langmuir, Peter
    Srinivas, Nithya
    Pratta, Michael
    Perales, Miguel-Angel
    Chen, Yi-Bin
    Meyers, Gabrielle
    DiPersio, John F.
    BLOOD ADVANCES, 2020, 4 (08) : 1656 - 1669
  • [5] Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases
    Covington, Maryanne
    He, Xin
    Scuron, Monika
    Li, Jun
    Collins, Robert
    Juvekar, Ashish
    Shin, Niu
    Favata, Margaret
    Gallagher, Karen
    Sarah, Sarala
    Xue, Chu-biao
    Peel, Michael
    Burke, Krista
    Oliver, Julian
    Fay, Brittany
    Yao, Wenqing
    Huang, Taisheng
    Scherle, Peggy
    Diamond, Sharon
    Newton, Robert
    Zhang, Yan
    Smith, Paul
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 885
  • [6] Multiple developmental and cytokine signaling abnormalities in JAK-1 knockout (JAK-1(-/-)) mice
    Rodig, SJ
    Meraz, MA
    White, JM
    Aguet, M
    Schreiber, RD
    JOURNAL OF LEUKOCYTE BIOLOGY, 1996, : 8 - 8
  • [7] The safety of JAK-1 inhibitors
    Clarke, Benjamin
    Yates, Mark
    Adas, Maryam
    Bechman, Katie
    Galloway, James
    RHEUMATOLOGY, 2021, 60 (SUPPL 2) : ii24 - ii30
  • [8] Development and Validation of an HPLC Method for Quantification of Filgotinib, a Novel JAK-1 Inhibitor in Mice Plasma: Application to a Pharmacokinetic Study
    Zakkula, Ashok
    Pulipati, Shobha
    Dittakavi, Sreekanth
    Bestha, Ram Murthi
    Zainuddin, Mohd
    Trivedi, Ravi Kumar
    Mullangi, Ramesh
    DRUG RESEARCH, 2020, 70 (05) : 233 - 238
  • [9] The safety of JAK-1 inhibitors
    Clarke, Benjamin
    Yates, Mark
    Adas, Maryam
    Bechman, Katie
    Galloway, James
    RHEUMATOLOGY, 2021, 60 : II24 - II30
  • [10] Itacitinib, a JAK1 Selective Inhibitor is highly efficacious in a MHC-mismatched mouse model of acute GvHD
    Juvekar, Ashish
    Ruggeri, Bruce
    Condon, Sindy
    Smith, Paul
    Scherle, Peggy
    Montgomery, Michael
    Delaite, Patricia
    Beal, Dominic
    Borkowski, Andrew
    BONE MARROW TRANSPLANTATION, 2018, 53 : 472 - 472
12345